Table 2.
Treatments | Gene Symbol | Gene Description | Expression Level | log2FoldChange | p Value |
---|---|---|---|---|---|
B vs. A | ALDH1L2 | aldehyde dehydrogenase 1 family member L2 | Down | −0.6 | <0.01 |
C vs. A | BTN1A1 | butyrophilin subfamily 1 member A1-like | Up | 0.4 | 0.02 |
D vs. A | AVD | Avidin | Up | 0.5 | <0.01 |
E vs. A | ST8SIA6 | ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6 | Up | 0.6 | <0.01 |
CUBN | Cubilin | Down | −0.7 | 0.01 | |
F vs. A | ALDH1L2 | aldehyde dehydrogenase 1 family member L2 | Down | −0.6 | 0.01 |
1 Treatments include (A) negative control treatment—chicks fed a basal corn-soybean meal-wheat-based diet; (B) in-feed antibiotics-chicks fed NC + 0.05% bacitracin methylene disalicylate; (C) in-water essential oil—chicks supplied the essential oil via the water route at the recommended dosage of 250 mL/1000 L of drinking water; (D) in ovo saline treatment—eggs injected with 0.2 mL of physiological saline (0.9% NaCl); (E) in ovo essential oil treatment—eggs injected with 0.2 mL of a saline + essential oil blend mixture at a dilution ratio of 2:1; (F) in ovo + in-water essential oil treatment-chicks offered the essential oil blend via the in ovo and in water route, successively. Each comparison is specified in the format “B vs. A”, where group B is compared to group A, with group A being the denominator for the comparison. Liver tissues (50–100 mg) were sampled from 8 replicate birds/treatment (independent of sex) using 1 mL TRIzol™ (Qiagen, Hilden, Germany).